Quick Answer
Milestone Pharmaceuticals Inc. reported Net Income of -$63.06 million for fiscal year 2025.
Milestone Pharmaceuticals Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$63.06M | -51.9% |
| 2024 | -$41.52M | +30.4% |
| 2023 | -$59.69M | -2.2% |
| 2022 | -$58.39M | -36.3% |
| 2021 | -$42.85M | +14.2% |
| 2020 | -$49.97M | +9.5% |
| 2019 | -$55.23M | -138.2% |
| 2018 | -$23.18M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$11.92M | -26.3% | +8.1% |
| June 30, 2025 | -$12.97M | -38.5% | +37.5% |
| March 31, 2025 | -$20.76M | -100.5% | -119.9% |
| September 30, 2024 | -$9.44M | +37.4% | -0.8% |
| June 30, 2024 | -$9.36M | +41.6% | +9.6% |
| March 31, 2024 | -$10.35M | +30.7% | +31.3% |
| September 30, 2023 | -$15.08M | -3.6% | +6.0% |
| June 30, 2023 | -$16.04M | +3.6% | -7.3% |
- Milestone Pharmaceuticals Inc. showed a decrease of -51.9% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Milestone Pharmaceuticals Inc.’s net income has declined by 172.0% (from -$23.18 million to -$63.06 million).
- The most recent figure is from Milestone Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: